Oregon Marijuana Company Launches Cannabis For Opioids Swap

“Numerous studies, including those reported by Newsweek, NBC News, US News and World Report, CNN and others, have shown that states with legal marijuana programs have declining rates of opioid addiction, with some states reporting a decrease in deaths as high as 25%. We want to help people in the communities we serve, as well as demonstrate that cannabis companies can be part of the President’s solution to the crisis.”

OREGON: Kaya Holdings has announced it will be holding talks with Oregon state and local law enforcement authorities and compliance officials to launch “Kaya Cares,” a Cannabis-for-Opioids swap program whereby people dependent on opioids and wishing to explore cannabis as a safe alternative can exchange their prescription opioids for cannabis products at no cost. “We decided Read the full article…

Patients Dramatically Reduce Their Opioid Use Following Cannabis Access

MMJ reduces opioid use

CANADA: Pain patients enrolled in Canada’s legal medical cannabis access program significantly reduce their use of opioids over the long-term, according to longitudinal data provided by Tilray Canada Ltd - one of the nation’s largest, licensed provider of medicinal marijuana products. Investigators assessed opioid use patterns in a cohort of 573 patients using Tilray-provided products. Among those patients who acknowledged Read the full article…

Patients Use Fewer Opioids Following Enrollment In Medical Cannabis Program

The study's findings are similar to those reported among enrollees in other states' medical cannabis programs, including the experiences of patients in Illinois, Michigan, Minnesota, New Mexico, and elsewhere.

NEW YORK:  Patients enrolled in New York state’s medical cannabis program reduce their use of opioids and spend less money on prescription medications, according to data published online in the journal Mental Health Clinician. Investigators from GPI Clinical Research labs in Rochester and the University of Buffalo assessed trends in patients’ medical cannabis and prescription drug use following Read the full article…